TOP2A and central nervous system cancer: Additionally, GSCs were enriched with genes previously linked to poor glioma outcomes, such as CENPF (57), TOP2A (58), NUSAP1 (59), PTTG1 (60), UBE2C (61), and UBE2S (62).